TAILIEUCHUNG - Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment - Subgroup Report on the Lowermoor Water Pollution Incident

Tham khảo sách 'committee on toxicity of chemicals in food, consumer products and the environment - subgroup report on the lowermoor water pollution incident', khoa học tự nhiên, công nghệ môi trường phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả | Committee on Toxicity of Chemicals in Food Consumer Products and the Environment Subgroup Report on the Lowermoor Water Pollution Incident Contents Chapter 1 Executive Summary 13 Chapter 2 Introduction 21 Historical perspective 21 Terms of reference of COT Subgroup 23 Membership of Subgroup 23 Methods of working 23 Dates of meetings and visits 25 Chapter 3 The Lowermoor water pollution incident water supply and contamination 27 Introduction 27 Lowermoor Water Treatment Works 27 The pollution incident 32 The distribution of contaminated water 33 The nature of the contamination of the water supply 33 Calculated values for the aluminium sulphate concentration in the Lowermoor Water Treatment Works 34 Collection of water samples for water quality analysis 35 Water quality data from SWWA and South West Water Ltd 36 Introduction 36 Pre-incident monitoring data 38 Results of monitoring - 7 July to 4 August 1988 41 Results of monitoring - 5 August to 31 December 1988 57 Results of monitoring - 1989 61 Monitoring data from other sources 63 Modelling of pollutant concentrations in Lowermoor treatment works and in trunk main system 64 Indications of copper concentrations in the contaminated water 72 Other water pollution incidents involving aluminium sulphate 73 Key points 73 Chapter 4 The assessment of exposure to contaminants 77 Introduction 77 Calculated estimates of exposure by the oral route 77 Water consumption data 77 Possible intakes from food 78 Water quality data 78 Estimated exposure to contaminants from 7 July to 4 August 1988 79 Estimated exposure to contaminants from 5 August 1988 to 31 December 1989 85 Modelling of exposure estimates 88 Modelling by Black and Veatch Consulting Ltd 88 Modelling by Crowther Clayton Associates Ltd 88 Dermal exposures 91 Key Points 91 Chapter 5 Evidence from individuals and population studies from the North Cornwall area 95 Introduction 95 Personal evidence 95 Population studies 95 Data from personal testimonies made by members of

• Môi trường
• Systemic Therapy
• Advanced Pancreatic Carcinoma
• Immunotherapy
• Overview
• Bacterial Immunotherapy
• Antitumoral Potential
• Hepatocellular carcinoma
• Systemic therapy for hepatocellular carcinoma
• Adjuvant regimens for HCC
• Sorafenib was first approved
• Prolong survival of the patients
• Barcelona Classification
• Summary of doctoral thesis
• Immune disorders and results of pulse methylprednisolone therapy
• Severe systemic lupus erythematosus
• Target organ damage and activity level
• Pulsed methylprednisolone therapy combined
• BMC Cancer
• Adjuvant temozolomide
• Multimodality therapy approaches
• Systemic treatment
• Radiation therapy
• BMC Pulmonary medicine
• Systemic glucocorticoid therapy
• Plasma metabolome
• Systemic glucocorticoid
• Acute exacerbation
• Chronic obstructive pulmonary disease
• Phase II trial
• Selective internal radiation therapy
• Systemic chemotherapy
• Liver predominant metastases
• Pancreatic adenocarcinoma
• Bladder cancer
• Radical cystectomy
• Perioperative chemotherapy
• Perioperative targeted therapy
• Immune therapy
• Gene therapy
• Human HCC cells
• Modified molecule
• Systemic HCC therapy
• Ewing sarcoma
• Complete remission
• Metastatic disease
• Distant metastasis
• Biliary cancer
• Younger patients
• Prospective trials
• Corticosteroids and steroid therapy
• Steroid therapy
• The manager
• Chronic subdural hematoma
• Clinical considerations
• Systemic autoimmune diseases
• Risk factors
• Intrauterine therapy
• Hormonal therapy
• Metritis in cattle
• Competitive mortality
• Non tumoral death
• Head and neck cancer
• Breast cancer
• Neoadjuvant systemic therapy
• Nodal staging
• Chest CT
• BMC Musculoskeletal Disorders
• Rheumatoid arthritis
• Systemic lupus erythematosus
• Autoimmune disorders
• Osteoporotic fractures
• BMC Anesthesiology
• Local anesthetic systemic toxicity
• Lipid rescue therapy
• Intravenous lipid emulsions
• Several international anesthesia organizations
• Carbon monoxide
• Life threatening
• Systemic hyperbaric oxygen
• CO detoxification
• Severely intoxicated patients
• Prognostic models
• Review and critical appraisal
• Advanced hepatocellular carcinoma
• Liver cancer
• Randomized controlled trial
• Systemic anticancer therapy
• Targeted therapy
• Non standard
• Survival outcomes
• Slow growing neoplasm
• Radiological response
• Pancreatic cancer
• Advanced disease
• Second line therapy Progression free survival
• Overall survival
• Biliary tract cancer
• Combination therapy
• Prior systemic therapies
• Prospective randomized
• Neoadjuvant treatment
• Endocrine therapy
• Treatment response
• Post treatment surgical management